Zhongchao Inc. (NASDAQ: ZCMD) Stock Competitors & Peer Comparison
See ZCMD's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for ZCMD and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ZCMD | $0.92 | -4.68% | 32.1K | -0.03 | -$29.70 | N/A |
| GEHCV | $56.00 | -4.08% | 25.5B | N/A | N/A | N/A |
| BTSG | $59.13 | -2.91% | 11.6B | 47.69 | $1.24 | N/A |
| BTSGU | $195.51 | -3.30% | 11.5B | 176.79 | $1.11 | N/A |
| TEM | $64.04 | -9.41% | 11.2B | -128.08 | -$0.50 | N/A |
| SGFY | $30.49 | +0.07% | 8.9B | 70.91 | $0.43 | N/A |
| HQY | $96.37 | +3.19% | 8.1B | 22.52 | $4.28 | N/A |
| TXG | $61.54 | -5.10% | 7.8B | -104.31 | -$0.59 | N/A |
| HNGE | $87.35 | -5.92% | 6.8B | 46.70 | $1.87 | N/A |
| RCM | $14.31 | N/A | 6B | -102.21 | -$0.14 | N/A |
Stock Comparison
GE HealthCare Technologies Inc. (NASDAQ: GEHCV)
ZCMD vs GEHCV Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, GEHCV has a market cap of 25.5B. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while GEHCV trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas GEHCV's P/E ratio is N/A. In terms of profitability, ZCMD's ROE is -0.32%, compared to GEHCV's ROE of +0.19%. Regarding short-term risk, ZCMD is more volatile compared to GEHCV. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check GEHCV's competition here
BrightSpring Health Services, Inc. Common Stock (NASDAQ: BTSG)
ZCMD vs BTSG Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, BTSG has a market cap of 11.6B. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while BTSG trades at $59.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas BTSG's P/E ratio is 47.69. In terms of profitability, ZCMD's ROE is -0.32%, compared to BTSG's ROE of +0.15%. Regarding short-term risk, ZCMD is more volatile compared to BTSG. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check BTSG's competition here
BrightSpring Health Services, Inc. Tangible Equity Unit (NASDAQ: BTSGU)
ZCMD vs BTSGU Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, BTSGU has a market cap of 11.5B. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while BTSGU trades at $195.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas BTSGU's P/E ratio is 176.79. In terms of profitability, ZCMD's ROE is -0.32%, compared to BTSGU's ROE of +0.15%. Regarding short-term risk, ZCMD is more volatile compared to BTSGU. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check BTSGU's competition here
Tempus AI, Inc. (NASDAQ: TEM)
ZCMD vs TEM Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, TEM has a market cap of 11.2B. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while TEM trades at $64.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas TEM's P/E ratio is -128.08. In terms of profitability, ZCMD's ROE is -0.32%, compared to TEM's ROE of -0.55%. Regarding short-term risk, ZCMD is more volatile compared to TEM. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check TEM's competition here
Signify Health, Inc. (NYSE: SGFY)
ZCMD vs SGFY Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, SGFY has a market cap of 8.9B. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while SGFY trades at $30.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas SGFY's P/E ratio is 70.91. In terms of profitability, ZCMD's ROE is -0.32%, compared to SGFY's ROE of -0.15%. Regarding short-term risk, ZCMD is more volatile compared to SGFY. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check SGFY's competition here
HealthEquity, Inc. (NASDAQ: HQY)
ZCMD vs HQY Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, HQY has a market cap of 8.1B. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while HQY trades at $96.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas HQY's P/E ratio is 22.52. In terms of profitability, ZCMD's ROE is -0.32%, compared to HQY's ROE of +0.11%. Regarding short-term risk, ZCMD is more volatile compared to HQY. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check HQY's competition here
10x Genomics, Inc. (NASDAQ: TXG)
ZCMD vs TXG Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, TXG has a market cap of 7.8B. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while TXG trades at $61.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas TXG's P/E ratio is -104.31. In terms of profitability, ZCMD's ROE is -0.32%, compared to TXG's ROE of -0.09%. Regarding short-term risk, ZCMD is more volatile compared to TXG. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check TXG's competition here
Hinge Health, Inc. (NYSE: HNGE)
ZCMD vs HNGE Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, HNGE has a market cap of 6.8B. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while HNGE trades at $87.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas HNGE's P/E ratio is 46.70. In terms of profitability, ZCMD's ROE is -0.32%, compared to HNGE's ROE of +0.30%. Regarding short-term risk, ZCMD is more volatile compared to HNGE. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check HNGE's competition here
R1 RCM Inc. (NASDAQ: RCM)
ZCMD vs RCM Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, RCM has a market cap of 6B. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while RCM trades at $14.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas RCM's P/E ratio is -102.21. In terms of profitability, ZCMD's ROE is -0.32%, compared to RCM's ROE of +0.00%. Regarding short-term risk, ZCMD is more volatile compared to RCM. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check RCM's competition here
Waystar Holding Corp. (NASDAQ: WAY)
ZCMD vs WAY Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, WAY has a market cap of 5B. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while WAY trades at $26.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas WAY's P/E ratio is 17.38. In terms of profitability, ZCMD's ROE is -0.32%, compared to WAY's ROE of +0.04%. Regarding short-term risk, ZCMD is more volatile compared to WAY. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check WAY's competition here
Doximity, Inc. (NYSE: DOCS)
ZCMD vs DOCS Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, DOCS has a market cap of 5B. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while DOCS trades at $26.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas DOCS's P/E ratio is 17.47. In terms of profitability, ZCMD's ROE is -0.32%, compared to DOCS's ROE of +0.17%. Regarding short-term risk, ZCMD is more volatile compared to DOCS. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check DOCS's competition here
Heartflow, Inc. Common Stock (NASDAQ: HTFL)
ZCMD vs HTFL Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, HTFL has a market cap of 4.1B. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while HTFL trades at $47.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas HTFL's P/E ratio is -23.77. In terms of profitability, ZCMD's ROE is -0.32%, compared to HTFL's ROE of -0.42%. Regarding short-term risk, ZCMD is more volatile compared to HTFL. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check HTFL's competition here
1Life Healthcare, Inc. (NASDAQ: ONEM)
ZCMD vs ONEM Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, ONEM has a market cap of 3.4B. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while ONEM trades at $16.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas ONEM's P/E ratio is -7.77. In terms of profitability, ZCMD's ROE is -0.32%, compared to ONEM's ROE of -0.24%. Regarding short-term risk, ZCMD is more volatile compared to ONEM. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check ONEM's competition here
Privia Health Group, Inc. (NASDAQ: PRVA)
ZCMD vs PRVA Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, PRVA has a market cap of 2.6B. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while PRVA trades at $20.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas PRVA's P/E ratio is 99.00. In terms of profitability, ZCMD's ROE is -0.32%, compared to PRVA's ROE of +0.00%. Regarding short-term risk, ZCMD is more volatile compared to PRVA. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check PRVA's competition here
NextGen Healthcare, Inc. (NASDAQ: NXGN)
ZCMD vs NXGN Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, NXGN has a market cap of 1.6B. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while NXGN trades at $23.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas NXGN's P/E ratio is -266.00. In terms of profitability, ZCMD's ROE is -0.32%, compared to NXGN's ROE of -0.01%. Regarding short-term risk, ZCMD is more volatile compared to NXGN. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check NXGN's competition here
Omnicell, Inc. (NASDAQ: OMCL)
ZCMD vs OMCL Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, OMCL has a market cap of 1.5B. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while OMCL trades at $33.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas OMCL's P/E ratio is 17.32. In terms of profitability, ZCMD's ROE is -0.32%, compared to OMCL's ROE of +0.03%. Regarding short-term risk, ZCMD is more volatile compared to OMCL. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check OMCL's competition here
Omada Health (NASDAQ: OMDA)
ZCMD vs OMDA Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, OMDA has a market cap of 1.4B. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while OMDA trades at $23.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas OMDA's P/E ratio is 338.43. In terms of profitability, ZCMD's ROE is -0.32%, compared to OMDA's ROE of +0.02%. Regarding short-term risk, ZCMD is more volatile compared to OMDA. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check OMDA's competition here
Agiliti, Inc. (NYSE: AGTI)
ZCMD vs AGTI Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, AGTI has a market cap of 1.4B. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while AGTI trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas AGTI's P/E ratio is -71.79. In terms of profitability, ZCMD's ROE is -0.32%, compared to AGTI's ROE of -0.02%. Regarding short-term risk, ZCMD is more volatile compared to AGTI. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check AGTI's competition here
Certara, Inc. (NASDAQ: CERT)
ZCMD vs CERT Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, CERT has a market cap of 1.3B. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while CERT trades at $8.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas CERT's P/E ratio is 20.87. In terms of profitability, ZCMD's ROE is -0.32%, compared to CERT's ROE of -0.07%. Regarding short-term risk, ZCMD is more volatile compared to CERT. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check CERT's competition here
GoodRx Holdings, Inc. (NASDAQ: GDRX)
ZCMD vs GDRX Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, GDRX has a market cap of 1.2B. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while GDRX trades at $3.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas GDRX's P/E ratio is 11.03. In terms of profitability, ZCMD's ROE is -0.32%, compared to GDRX's ROE of +0.03%. Regarding short-term risk, ZCMD is more volatile compared to GDRX. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check GDRX's competition here
Teladoc Health, Inc. (NYSE: TDOC)
ZCMD vs TDOC Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, TDOC has a market cap of 1.2B. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while TDOC trades at $6.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas TDOC's P/E ratio is -6.57. In terms of profitability, ZCMD's ROE is -0.32%, compared to TDOC's ROE of -0.13%. Regarding short-term risk, ZCMD is more volatile compared to TDOC. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check TDOC's competition here
HealthStream, Inc. (NASDAQ: HSTM)
ZCMD vs HSTM Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, HSTM has a market cap of 858.3M. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while HSTM trades at $29.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas HSTM's P/E ratio is 40.81. In terms of profitability, ZCMD's ROE is -0.32%, compared to HSTM's ROE of +0.06%. Regarding short-term risk, ZCMD is more volatile compared to HSTM. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check HSTM's competition here
CareCloud, Inc. (NASDAQ: CCLDO)
ZCMD vs CCLDO Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, CCLDO has a market cap of 857.3M. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while CCLDO trades at $27.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas CCLDO's P/E ratio is N/A. In terms of profitability, ZCMD's ROE is -0.32%, compared to CCLDO's ROE of +0.17%. Regarding short-term risk, ZCMD is more volatile compared to CCLDO. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check CCLDO's competition here
Phreesia, Inc. (NYSE: PHR)
ZCMD vs PHR Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, PHR has a market cap of 750.4M. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while PHR trades at $12.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas PHR's P/E ratio is 43.36. In terms of profitability, ZCMD's ROE is -0.32%, compared to PHR's ROE of +0.03%. Regarding short-term risk, ZCMD is more volatile compared to PHR. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check PHR's competition here
SOPHiA GENETICS S.A. (NASDAQ: SOPH)
ZCMD vs SOPH Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, SOPH has a market cap of 682.9M. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while SOPH trades at $8.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas SOPH's P/E ratio is -7.33. In terms of profitability, ZCMD's ROE is -0.32%, compared to SOPH's ROE of -1.37%. Regarding short-term risk, ZCMD is more volatile compared to SOPH. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check SOPH's competition here
Claritev Corporation (NYSE: CTEV)
ZCMD vs CTEV Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, CTEV has a market cap of 669.3M. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while CTEV trades at $39.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas CTEV's P/E ratio is -2.31. In terms of profitability, ZCMD's ROE is -0.32%, compared to CTEV's ROE of +1.40%. Regarding short-term risk, ZCMD is more volatile compared to CTEV. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check CTEV's competition here
MultiPlan Corporation (NYSE: MPLN-WT)
ZCMD vs MPLN-WT Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, MPLN-WT has a market cap of 625.2M. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while MPLN-WT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas MPLN-WT's P/E ratio is N/A. In terms of profitability, ZCMD's ROE is -0.32%, compared to MPLN-WT's ROE of +1.40%. Regarding short-term risk, ZCMD is less volatile compared to MPLN-WT. This indicates lower risk in terms of short-term price fluctuations for ZCMD.Check MPLN-WT's competition here
Accolade, Inc. (NASDAQ: ACCD)
ZCMD vs ACCD Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, ACCD has a market cap of 575.6M. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while ACCD trades at $7.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas ACCD's P/E ratio is -3.08. In terms of profitability, ZCMD's ROE is -0.32%, compared to ACCD's ROE of -0.22%. Regarding short-term risk, ZCMD is more volatile compared to ACCD. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check ACCD's competition here
Sharecare, Inc. (NASDAQ: SHCR)
ZCMD vs SHCR Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, SHCR has a market cap of 531.8M. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while SHCR trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas SHCR's P/E ratio is -3.76. In terms of profitability, ZCMD's ROE is -0.32%, compared to SHCR's ROE of -0.25%. Regarding short-term risk, ZCMD is more volatile compared to SHCR. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check SHCR's competition here
Evolent Health, Inc. (NYSE: EVH)
ZCMD vs EVH Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, EVH has a market cap of 518M. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while EVH trades at $4.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas EVH's P/E ratio is 35.42. In terms of profitability, ZCMD's ROE is -0.32%, compared to EVH's ROE of -0.99%. Regarding short-term risk, ZCMD is more volatile compared to EVH. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check EVH's competition here
NRC Health (NASDAQ: NRC)
ZCMD vs NRC Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, NRC has a market cap of 492.4M. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while NRC trades at $21.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas NRC's P/E ratio is 26.65. In terms of profitability, ZCMD's ROE is -0.32%, compared to NRC's ROE of +0.48%. Regarding short-term risk, ZCMD is more volatile compared to NRC. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check NRC's competition here
SomaLogic, Inc. (NASDAQ: SLGC)
ZCMD vs SLGC Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, SLGC has a market cap of 396.2M. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while SLGC trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas SLGC's P/E ratio is -3.04. In terms of profitability, ZCMD's ROE is -0.32%, compared to SLGC's ROE of -0.19%. Regarding short-term risk, ZCMD is less volatile compared to SLGC. This indicates lower risk in terms of short-term price fluctuations for ZCMD.Check SLGC's competition here
SomaLogic, Inc. (NASDAQ: SLGCW)
ZCMD vs SLGCW Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, SLGCW has a market cap of 396.2M. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while SLGCW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas SLGCW's P/E ratio is -0.16. In terms of profitability, ZCMD's ROE is -0.32%, compared to SLGCW's ROE of -0.19%. Regarding short-term risk, ZCMD is less volatile compared to SLGCW. This indicates lower risk in terms of short-term price fluctuations for ZCMD.Check SLGCW's competition here
TruBridge, Inc. (NASDAQ: TBRG)
ZCMD vs TBRG Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, TBRG has a market cap of 393.6M. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while TBRG trades at $26.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas TBRG's P/E ratio is 9.37. In terms of profitability, ZCMD's ROE is -0.32%, compared to TBRG's ROE of +0.02%. Regarding short-term risk, ZCMD is more volatile compared to TBRG. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check TBRG's competition here
MultiPlan Corporation (NYSE: MPLN)
ZCMD vs MPLN Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, MPLN has a market cap of 375M. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while MPLN trades at $23.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas MPLN's P/E ratio is -0.23. In terms of profitability, ZCMD's ROE is -0.32%, compared to MPLN's ROE of +1.40%. Regarding short-term risk, ZCMD is more volatile compared to MPLN. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check MPLN's competition here
So-Young International Inc. (NASDAQ: SY)
ZCMD vs SY Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, SY has a market cap of 314.9M. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while SY trades at $2.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas SY's P/E ratio is -7.27. In terms of profitability, ZCMD's ROE is -0.32%, compared to SY's ROE of -0.16%. Regarding short-term risk, ZCMD is more volatile compared to SY. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check SY's competition here
Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC)
ZCMD vs TRHC Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, TRHC has a market cap of 284M. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while TRHC trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas TRHC's P/E ratio is -4.27. In terms of profitability, ZCMD's ROE is -0.32%, compared to TRHC's ROE of +121.31%. Regarding short-term risk, ZCMD is more volatile compared to TRHC. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check TRHC's competition here
Sema4 Holdings Corp. (NASDAQ: SMFR)
ZCMD vs SMFR Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, SMFR has a market cap of 246.4M. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while SMFR trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas SMFR's P/E ratio is N/A. In terms of profitability, ZCMD's ROE is -0.32%, compared to SMFR's ROE of -0.39%. Regarding short-term risk, ZCMD is less volatile compared to SMFR. This indicates lower risk in terms of short-term price fluctuations for ZCMD.Check SMFR's competition here
Spok Holdings, Inc. (NASDAQ: SPOK)
ZCMD vs SPOK Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, SPOK has a market cap of 222.4M. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while SPOK trades at $10.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas SPOK's P/E ratio is 17.75. In terms of profitability, ZCMD's ROE is -0.32%, compared to SPOK's ROE of +0.09%. Regarding short-term risk, ZCMD is more volatile compared to SPOK. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check SPOK's competition here
American Well Corporation (NYSE: AMWL)
ZCMD vs AMWL Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, AMWL has a market cap of 202.2M. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while AMWL trades at $11.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas AMWL's P/E ratio is -2.69. In terms of profitability, ZCMD's ROE is -0.32%, compared to AMWL's ROE of -0.33%. Regarding short-term risk, ZCMD is more volatile compared to AMWL. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check AMWL's competition here
LifeMD, Inc. (NASDAQ: LFMDP)
ZCMD vs LFMDP Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, LFMDP has a market cap of 156.9M. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while LFMDP trades at $23.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas LFMDP's P/E ratio is -709.24. In terms of profitability, ZCMD's ROE is -0.32%, compared to LFMDP's ROE of -1.79%. Regarding short-term risk, ZCMD is more volatile compared to LFMDP. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check LFMDP's competition here
LifeMD, Inc. (NASDAQ: LFMD)
ZCMD vs LFMD Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, LFMD has a market cap of 151.9M. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while LFMD trades at $3.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas LFMD's P/E ratio is -6.28. In terms of profitability, ZCMD's ROE is -0.32%, compared to LFMD's ROE of -1.79%. Regarding short-term risk, ZCMD is more volatile compared to LFMD. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check LFMD's competition here
OptimizeRx Corp. (NASDAQ: OPRX)
ZCMD vs OPRX Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, OPRX has a market cap of 149.2M. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while OPRX trades at $7.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas OPRX's P/E ratio is 7.29. In terms of profitability, ZCMD's ROE is -0.32%, compared to OPRX's ROE of +0.04%. Regarding short-term risk, ZCMD is more volatile compared to OPRX. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check OPRX's competition here
Computer Programs and Systems, Inc. (NASDAQ: CPSI)
ZCMD vs CPSI Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, CPSI has a market cap of 133.7M. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while CPSI trades at $9.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas CPSI's P/E ratio is -183.80. In terms of profitability, ZCMD's ROE is -0.32%, compared to CPSI's ROE of +0.02%. Regarding short-term risk, ZCMD is more volatile compared to CPSI. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check CPSI's competition here
Health Catalyst, Inc. (NASDAQ: HCAT)
ZCMD vs HCAT Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, HCAT has a market cap of 117.5M. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while HCAT trades at $1.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas HCAT's P/E ratio is 7.95. In terms of profitability, ZCMD's ROE is -0.32%, compared to HCAT's ROE of -1.30%. Regarding short-term risk, ZCMD is more volatile compared to HCAT. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check HCAT's competition here
Augmedix, Inc. (NASDAQ: AUGX)
ZCMD vs AUGX Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, AUGX has a market cap of 115.9M. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while AUGX trades at $2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas AUGX's P/E ratio is -4.99. In terms of profitability, ZCMD's ROE is -0.32%, compared to AUGX's ROE of -1.55%. Regarding short-term risk, ZCMD is more volatile compared to AUGX. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check AUGX's competition here
CareCloud, Inc. (NASDAQ: CCLD)
ZCMD vs CCLD Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, CCLD has a market cap of 105.8M. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while CCLD trades at $2.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas CCLD's P/E ratio is 9.58. In terms of profitability, ZCMD's ROE is -0.32%, compared to CCLD's ROE of +0.17%. Regarding short-term risk, ZCMD is more volatile compared to CCLD. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check CCLD's competition here
SCWorx Corp. (NASDAQ: WORX)
ZCMD vs WORX Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, WORX has a market cap of 88M. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while WORX trades at $5.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas WORX's P/E ratio is -6.40. In terms of profitability, ZCMD's ROE is -0.32%, compared to WORX's ROE of -0.35%. Regarding short-term risk, ZCMD is less volatile compared to WORX. This indicates lower risk in terms of short-term price fluctuations for ZCMD.Check WORX's competition here
Definitive Healthcare Corp. (NASDAQ: DH)
ZCMD vs DH Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, DH has a market cap of 84.7M. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while DH trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas DH's P/E ratio is 3.09. In terms of profitability, ZCMD's ROE is -0.32%, compared to DH's ROE of -0.79%. Regarding short-term risk, ZCMD is more volatile compared to DH. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check DH's competition here
Forian Inc. (NASDAQ: FORA)
ZCMD vs FORA Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, FORA has a market cap of 67.8M. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while FORA trades at $2.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas FORA's P/E ratio is -24.11. In terms of profitability, ZCMD's ROE is -0.32%, compared to FORA's ROE of -0.17%. Regarding short-term risk, ZCMD is more volatile compared to FORA. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check FORA's competition here
CareCloud, Inc. (NASDAQ: CCLDP)
ZCMD vs CCLDP Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, CCLDP has a market cap of 59.9M. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while CCLDP trades at $19.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas CCLDP's P/E ratio is N/A. In terms of profitability, ZCMD's ROE is -0.32%, compared to CCLDP's ROE of +0.17%. Regarding short-term risk, ZCMD is more volatile compared to CCLDP. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check CCLDP's competition here
Science 37 Holdings, Inc. (NASDAQ: SNCE)
ZCMD vs SNCE Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, SNCE has a market cap of 34.7M. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while SNCE trades at $5.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas SNCE's P/E ratio is -0.27. In terms of profitability, ZCMD's ROE is -0.32%, compared to SNCE's ROE of -0.47%. Regarding short-term risk, ZCMD is more volatile compared to SNCE. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check SNCE's competition here
Akili, Inc. (NASDAQ: AKLI)
ZCMD vs AKLI Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, AKLI has a market cap of 34.1M. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while AKLI trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas AKLI's P/E ratio is -0.71. In terms of profitability, ZCMD's ROE is -0.32%, compared to AKLI's ROE of -0.70%. Regarding short-term risk, ZCMD is more volatile compared to AKLI. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check AKLI's competition here
SHL Telemedicine Ltd. (NASDAQ: SHLT)
ZCMD vs SHLT Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, SHLT has a market cap of 33.6M. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while SHLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas SHLT's P/E ratio is -3.87. In terms of profitability, ZCMD's ROE is -0.32%, compared to SHLT's ROE of -0.50%. Regarding short-term risk, ZCMD is more volatile compared to SHLT. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check SHLT's competition here
OneMedNet Corporation (NASDAQ: ONMD)
ZCMD vs ONMD Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, ONMD has a market cap of 33M. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while ONMD trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas ONMD's P/E ratio is -3.62. In terms of profitability, ZCMD's ROE is -0.32%, compared to ONMD's ROE of +2.35%. Regarding short-term risk, ZCMD is more volatile compared to ONMD. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check ONMD's competition here
Sharecare, Inc. (NASDAQ: SHCRW)
ZCMD vs SHCRW Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, SHCRW has a market cap of 32.5M. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while SHCRW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas SHCRW's P/E ratio is -0.00. In terms of profitability, ZCMD's ROE is -0.32%, compared to SHCRW's ROE of -0.25%. Regarding short-term risk, ZCMD is more volatile compared to SHCRW. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check SHCRW's competition here
OneMedNet Corporation (NASDAQ: ONMDW)
ZCMD vs ONMDW Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, ONMDW has a market cap of 31.1M. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while ONMDW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas ONMDW's P/E ratio is N/A. In terms of profitability, ZCMD's ROE is -0.32%, compared to ONMDW's ROE of +2.35%. Regarding short-term risk, ZCMD is less volatile compared to ONMDW. This indicates lower risk in terms of short-term price fluctuations for ZCMD.Check ONMDW's competition here
Streamline Health Solutions, Inc. (NASDAQ: STRM)
ZCMD vs STRM Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, STRM has a market cap of 23.2M. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while STRM trades at $5.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas STRM's P/E ratio is -2.40. In terms of profitability, ZCMD's ROE is -0.32%, compared to STRM's ROE of -0.65%. Regarding short-term risk, ZCMD is more volatile compared to STRM. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check STRM's competition here
Renalytix Plc (NASDAQ: RNLX)
ZCMD vs RNLX Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, RNLX has a market cap of 22.5M. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while RNLX trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas RNLX's P/E ratio is -0.33. In terms of profitability, ZCMD's ROE is -0.32%, compared to RNLX's ROE of -6.31%. Regarding short-term risk, ZCMD is less volatile compared to RNLX. This indicates lower risk in terms of short-term price fluctuations for ZCMD.Check RNLX's competition here
MSP Recovery, Inc. (NASDAQ: LIFW)
ZCMD vs LIFW Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, LIFW has a market cap of 22.4M. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while LIFW trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas LIFW's P/E ratio is -0.02. In terms of profitability, ZCMD's ROE is -0.32%, compared to LIFW's ROE of +1.56%. Regarding short-term risk, ZCMD is more volatile compared to LIFW. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check LIFW's competition here
Babylon Holdings Limited (NYSE: BBLN)
ZCMD vs BBLN Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, BBLN has a market cap of 14.1M. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while BBLN trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas BBLN's P/E ratio is -0.04. In terms of profitability, ZCMD's ROE is -0.32%, compared to BBLN's ROE of +4.89%. Regarding short-term risk, ZCMD is less volatile compared to BBLN. This indicates lower risk in terms of short-term price fluctuations for ZCMD.Check BBLN's competition here
Bullfrog AI Holdings, Inc. Common Stock (NASDAQ: BFRG)
ZCMD vs BFRG Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, BFRG has a market cap of 10.1M. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while BFRG trades at $0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas BFRG's P/E ratio is -1.18. In terms of profitability, ZCMD's ROE is -0.32%, compared to BFRG's ROE of -1.50%. Regarding short-term risk, ZCMD is more volatile compared to BFRG. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check BFRG's competition here
ETAO International Co., Ltd. (NASDAQ: ETAO)
ZCMD vs ETAO Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, ETAO has a market cap of 9.8M. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while ETAO trades at $1.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas ETAO's P/E ratio is -0.01. In terms of profitability, ZCMD's ROE is -0.32%, compared to ETAO's ROE of -13.69%. Regarding short-term risk, ZCMD is less volatile compared to ETAO. This indicates lower risk in terms of short-term price fluctuations for ZCMD.Check ETAO's competition here
Mangoceuticals, Inc. (NASDAQ: MGRX)
ZCMD vs MGRX Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, MGRX has a market cap of 6.8M. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while MGRX trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas MGRX's P/E ratio is -0.30. In terms of profitability, ZCMD's ROE is -0.32%, compared to MGRX's ROE of -1.06%. Regarding short-term risk, ZCMD is more volatile compared to MGRX. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check MGRX's competition here
UpHealth, Inc. (NYSE: UPH)
ZCMD vs UPH Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, UPH has a market cap of 5.3M. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while UPH trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas UPH's P/E ratio is -0.07. In terms of profitability, ZCMD's ROE is -0.32%, compared to UPH's ROE of -1.05%. Regarding short-term risk, ZCMD is less volatile compared to UPH. This indicates lower risk in terms of short-term price fluctuations for ZCMD.Check UPH's competition here
UpHealth, Inc. (NYSE: UPH-WT)
ZCMD vs UPH-WT Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, UPH-WT has a market cap of 5.3M. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while UPH-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas UPH-WT's P/E ratio is N/A. In terms of profitability, ZCMD's ROE is -0.32%, compared to UPH-WT's ROE of -1.05%. Regarding short-term risk, ZCMD is less volatile compared to UPH-WT. This indicates lower risk in terms of short-term price fluctuations for ZCMD.Check UPH-WT's competition here
Pear Therapeutics, Inc. (NASDAQ: PEAR)
ZCMD vs PEAR Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, PEAR has a market cap of 4.1M. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while PEAR trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas PEAR's P/E ratio is -0.08. In terms of profitability, ZCMD's ROE is -0.32%, compared to PEAR's ROE of -0.39%. Regarding short-term risk, ZCMD is less volatile compared to PEAR. This indicates lower risk in terms of short-term price fluctuations for ZCMD.Check PEAR's competition here
Pear Therapeutics, Inc. (NASDAQ: PEARW)
ZCMD vs PEARW Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, PEARW has a market cap of 4.1M. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while PEARW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas PEARW's P/E ratio is -0.00. In terms of profitability, ZCMD's ROE is -0.32%, compared to PEARW's ROE of -0.39%. Regarding short-term risk, ZCMD is less volatile compared to PEARW. This indicates lower risk in terms of short-term price fluctuations for ZCMD.Check PEARW's competition here
Ontrak, Inc. (NASDAQ: OTRK)
ZCMD vs OTRK Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, OTRK has a market cap of 2.3M. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while OTRK trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas OTRK's P/E ratio is -0.02. In terms of profitability, ZCMD's ROE is -0.32%, compared to OTRK's ROE of -2.11%. Regarding short-term risk, ZCMD is more volatile compared to OTRK. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check OTRK's competition here
CareMax, Inc. (NASDAQ: CMAX)
ZCMD vs CMAX Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, CMAX has a market cap of 1.6M. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while CMAX trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas CMAX's P/E ratio is -0.00. In terms of profitability, ZCMD's ROE is -0.32%, compared to CMAX's ROE of -2.01%. Regarding short-term risk, ZCMD is more volatile compared to CMAX. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check CMAX's competition here
Bullfrog AI Holdings, Inc. Warrants (NASDAQ: BFRGW)
ZCMD vs BFRGW Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, BFRGW has a market cap of 1.4M. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while BFRGW trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas BFRGW's P/E ratio is -0.92. In terms of profitability, ZCMD's ROE is -0.32%, compared to BFRGW's ROE of -1.50%. Regarding short-term risk, ZCMD is more volatile compared to BFRGW. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check BFRGW's competition here
Aclarion, Inc. (NASDAQ: ACON)
ZCMD vs ACON Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, ACON has a market cap of 1.3M. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while ACON trades at $2.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas ACON's P/E ratio is -0.27. In terms of profitability, ZCMD's ROE is -0.32%, compared to ACON's ROE of -0.59%. Regarding short-term risk, ZCMD is more volatile compared to ACON. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check ACON's competition here
MSP Recovery, Inc. (NASDAQ: LIFWZ)
ZCMD vs LIFWZ Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, LIFWZ has a market cap of 1.3M. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while LIFWZ trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas LIFWZ's P/E ratio is N/A. In terms of profitability, ZCMD's ROE is -0.32%, compared to LIFWZ's ROE of +1.56%. Regarding short-term risk, ZCMD is more volatile compared to LIFWZ. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check LIFWZ's competition here
Healthcare Triangle, Inc. (NASDAQ: HCTI)
ZCMD vs HCTI Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, HCTI has a market cap of 975.4K. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while HCTI trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas HCTI's P/E ratio is -0.11. In terms of profitability, ZCMD's ROE is -0.32%, compared to HCTI's ROE of -0.56%. Regarding short-term risk, ZCMD is more volatile compared to HCTI. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check HCTI's competition here
VSee Health, Inc. (NASDAQ: VSEEW)
ZCMD vs VSEEW Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, VSEEW has a market cap of 560.3K. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while VSEEW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas VSEEW's P/E ratio is -0.04. In terms of profitability, ZCMD's ROE is -0.32%, compared to VSEEW's ROE of -4.01%. Regarding short-term risk, ZCMD is less volatile compared to VSEEW. This indicates lower risk in terms of short-term price fluctuations for ZCMD.Check VSEEW's competition here
MSP Recovery, Inc. (NASDAQ: MSPRZ)
ZCMD vs MSPRZ Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, MSPRZ has a market cap of 550.4K. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while MSPRZ trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas MSPRZ's P/E ratio is N/A. In terms of profitability, ZCMD's ROE is -0.32%, compared to MSPRZ's ROE of +1.56%. Regarding short-term risk, ZCMD is less volatile compared to MSPRZ. This indicates lower risk in terms of short-term price fluctuations for ZCMD.Check MSPRZ's competition here
VSee Health, Inc. (NASDAQ: VSEE)
ZCMD vs VSEE Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, VSEE has a market cap of 245.6K. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while VSEE trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas VSEE's P/E ratio is -0.03. In terms of profitability, ZCMD's ROE is -0.32%, compared to VSEE's ROE of -4.01%. Regarding short-term risk, ZCMD is less volatile compared to VSEE. This indicates lower risk in terms of short-term price fluctuations for ZCMD.Check VSEE's competition here
Akerna Corp. (NASDAQ: KERNW)
ZCMD vs KERNW Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, KERNW has a market cap of 162.3K. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while KERNW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas KERNW's P/E ratio is -0.00. In terms of profitability, ZCMD's ROE is -0.32%, compared to KERNW's ROE of -0.20%. Regarding short-term risk, ZCMD is less volatile compared to KERNW. This indicates lower risk in terms of short-term price fluctuations for ZCMD.Check KERNW's competition here
Akerna Corp. (NASDAQ: KERN)
ZCMD vs KERN Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, KERN has a market cap of 162.3K. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while KERN trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas KERN's P/E ratio is -0.01. In terms of profitability, ZCMD's ROE is -0.32%, compared to KERN's ROE of -0.20%. Regarding short-term risk, ZCMD is less volatile compared to KERN. This indicates lower risk in terms of short-term price fluctuations for ZCMD.Check KERN's competition here
MSP Recovery, Inc. (NASDAQ: LIFWW)
ZCMD vs LIFWW Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, LIFWW has a market cap of 60.1K. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while LIFWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas LIFWW's P/E ratio is N/A. In terms of profitability, ZCMD's ROE is -0.32%, compared to LIFWW's ROE of +1.56%. Regarding short-term risk, ZCMD is more volatile compared to LIFWW. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check LIFWW's competition here
CareMax, Inc. (NASDAQ: CMAXW)
ZCMD vs CMAXW Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, CMAXW has a market cap of 36.4K. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while CMAXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas CMAXW's P/E ratio is N/A. In terms of profitability, ZCMD's ROE is -0.32%, compared to CMAXW's ROE of -2.01%. Regarding short-term risk, ZCMD is more volatile compared to CMAXW. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check CMAXW's competition here
Aclarion, Inc. (NASDAQ: ACONW)
ZCMD vs ACONW Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, ACONW has a market cap of 13.6K. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while ACONW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas ACONW's P/E ratio is N/A. In terms of profitability, ZCMD's ROE is -0.32%, compared to ACONW's ROE of -0.59%. Regarding short-term risk, ZCMD is more volatile compared to ACONW. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check ACONW's competition here
CareCloud, Inc. (NASDAQ: MTBC)
ZCMD vs MTBC Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, MTBC has a market cap of 0. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while MTBC trades at $3.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas MTBC's P/E ratio is N/A. In terms of profitability, ZCMD's ROE is -0.32%, compared to MTBC's ROE of +0.19%. Regarding short-term risk, ZCMD is less volatile compared to MTBC. This indicates lower risk in terms of short-term price fluctuations for ZCMD.Check MTBC's competition here
Convey Health Solutions Holdings, Inc. (NYSE: CNVY)
ZCMD vs CNVY Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, CNVY has a market cap of 0. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while CNVY trades at $10.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas CNVY's P/E ratio is -71.50. In terms of profitability, ZCMD's ROE is -0.32%, compared to CNVY's ROE of -0.02%. Regarding short-term risk, ZCMD is more volatile compared to CNVY. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check CNVY's competition here
CareCloud, Inc. (NASDAQ: MTBCO)
ZCMD vs MTBCO Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, MTBCO has a market cap of 0. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while MTBCO trades at $25.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas MTBCO's P/E ratio is N/A. In terms of profitability, ZCMD's ROE is -0.32%, compared to MTBCO's ROE of +0.17%. Regarding short-term risk, ZCMD is more volatile compared to MTBCO. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check MTBCO's competition here
CareCloud, Inc. (NASDAQ: MTBCP)
ZCMD vs MTBCP Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, MTBCP has a market cap of 0. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while MTBCP trades at $26.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas MTBCP's P/E ratio is N/A. In terms of profitability, ZCMD's ROE is -0.32%, compared to MTBCP's ROE of +0.17%. Regarding short-term risk, ZCMD is more volatile compared to MTBCP. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check MTBCP's competition here
Cerner Corporation (NASDAQ: CERN)
ZCMD vs CERN Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, CERN has a market cap of 0. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while CERN trades at $94.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas CERN's P/E ratio is 55.84. In terms of profitability, ZCMD's ROE is -0.32%, compared to CERN's ROE of +0.14%. Regarding short-term risk, ZCMD is more volatile compared to CERN. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check CERN's competition here
Change Healthcare Inc. (NASDAQ: CHNG)
ZCMD vs CHNG Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, CHNG has a market cap of 0. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while CHNG trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas CHNG's P/E ratio is -152.72. In terms of profitability, ZCMD's ROE is -0.32%, compared to CHNG's ROE of -0.05%. Regarding short-term risk, ZCMD is more volatile compared to CHNG. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check CHNG's competition here
Alkuri Global Acquisition Corp. (NASDAQ: KURIU)
ZCMD vs KURIU Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, KURIU has a market cap of 0. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while KURIU trades at $9.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas KURIU's P/E ratio is N/A. In terms of profitability, ZCMD's ROE is -0.32%, compared to KURIU's ROE of +1.06%. Regarding short-term risk, ZCMD is more volatile compared to KURIU. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check KURIU's competition here
Affymetrix, Inc. (NASDAQ: AFFX)
ZCMD vs AFFX Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, AFFX has a market cap of 0. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while AFFX trades at $14.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas AFFX's P/E ratio is N/A. In terms of profitability, ZCMD's ROE is -0.32%, compared to AFFX's ROE of +0.03%. Regarding short-term risk, ZCMD is more volatile compared to AFFX. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check AFFX's competition here
NantHealth, Inc. (NASDAQ: NH)
ZCMD vs NH Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, NH has a market cap of 0. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while NH trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas NH's P/E ratio is -0.12. In terms of profitability, ZCMD's ROE is -0.32%, compared to NH's ROE of +0.35%. Regarding short-term risk, ZCMD is less volatile compared to NH. This indicates lower risk in terms of short-term price fluctuations for ZCMD.Check NH's competition here
Castlight Health, Inc. (NYSE: CSLT)
ZCMD vs CSLT Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, CSLT has a market cap of 0. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while CSLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas CSLT's P/E ratio is -37.27. In terms of profitability, ZCMD's ROE is -0.32%, compared to CSLT's ROE of -0.42%. Regarding short-term risk, ZCMD is more volatile compared to CSLT. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check CSLT's competition here
Change Healthcare Inc. (NASDAQ: CHNGU)
ZCMD vs CHNGU Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, CHNGU has a market cap of 0. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while CHNGU trades at $73.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas CHNGU's P/E ratio is N/A. In terms of profitability, ZCMD's ROE is -0.32%, compared to CHNGU's ROE of -0.05%. Regarding short-term risk, ZCMD is more volatile compared to CHNGU. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check CHNGU's competition here
Nava Health MD, LLC (NASDAQ: NAVA)
ZCMD vs NAVA Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, NAVA has a market cap of 0. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while NAVA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas NAVA's P/E ratio is N/A. In terms of profitability, ZCMD's ROE is -0.32%, compared to NAVA's ROE of +0.15%. Regarding short-term risk, ZCMD is not fully comparable compared to NAVA. This indicates unavailable risk data in terms of short-term price fluctuations for ZCMD.Check NAVA's competition here
IMS Health Holdings, Inc. (NYSE: IMS)
ZCMD vs IMS Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, IMS has a market cap of 0. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while IMS trades at $31.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas IMS's P/E ratio is N/A. In terms of profitability, ZCMD's ROE is -0.32%, compared to IMS's ROE of +0.27%. Regarding short-term risk, ZCMD is more volatile compared to IMS. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check IMS's competition here
Sema4 Holdings Corp. (NASDAQ: SMFRW)
ZCMD vs SMFRW Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, SMFRW has a market cap of 0. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while SMFRW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas SMFRW's P/E ratio is N/A. In terms of profitability, ZCMD's ROE is -0.32%, compared to SMFRW's ROE of -0.39%. Regarding short-term risk, ZCMD is less volatile compared to SMFRW. This indicates lower risk in terms of short-term price fluctuations for ZCMD.Check SMFRW's competition here
MSP Recovery, Inc. (NASDAQ: MSPRV)
ZCMD vs MSPRV Comparison September 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 32.1K. In comparison, MSPRV has a market cap of 0. Regarding current trading prices, ZCMD is priced at $0.92 on the NASDAQ, while MSPRV trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.03, whereas MSPRV's P/E ratio is N/A. In terms of profitability, ZCMD's ROE is -0.32%, compared to MSPRV's ROE of N/A. Regarding short-term risk, ZCMD is less volatile compared to MSPRV. This indicates lower risk in terms of short-term price fluctuations for ZCMD.Check MSPRV's competition here